UMIN-ICDS History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000034815
Receipt number	R000039704
Scientific Title	Response-oriented sequential therapy with four cycles of bortezomib, melphalan, and prednisolone followed by continuous lenalidomide and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma
Date of disclosure of the study information	2018/11/08
Last modified on	2018/11/08 12:19:52

---